Prospectiev study of safety and efficiency of bronchial artery occlusion for lung and mediastinal tumor

Prospectiev study of safety and efficiency of bronchial artery occlusion for lung and mediastinal tumor - Prospectivey study of bronchial artery embolization for lung and mediastinal tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020187

Enrollment

100

Registered

2015-12-14

Start date

2015-12-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung and mediastinal malignant tumor

Interventions

Bronchial aretery embolization using NBCA, which is usually used for airway bleeding caused by inflammatory lesion, is used for reducing malignant lung and mediastinal tumor.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Malignant lung and mediastinal tumors. The tumor is located near hilum or mediastinum.

Exclusion criteria

Exclusion criteria: The patient who rejects the treatment after explaining the treatment.

Design outcomes

Primary

Measure	Time frame
Safety and anti-tumor effect of bronchial artery embolization for lung and mediastinal tumor are examined.Safety is checked by physical and radiological findings of spinal palsy, esophageal inflammation, and bronchial inflammation, within one week after the treatment. Anti-tumor effect is checked by CT, MRI, and FDG-PET for decreasing tumor around one month after the treatment.	—

Countries

Japan

Contacts

Public ContactHiroaki Nomori

Kameda Medical Center Thoracic Surgery

hnomori@qk9.so-net.ne.jp0470-92-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026